Maria Rita Gismondo

Italian physician and biologist

Born 1954-02-18 in Catania (Q1903)

Maria Rita Gismondo is …
instance of (P31):
humanQ5

External links are
P9085Aracne author IDmrgmiscl
P8214curriculum vitae URLhttps://www.asst-fbf-sacco.it/uploads/default/attachments/medici/medici_m/581/files/allegati/1867/cv_maria_rita_gismondo.pdf
P10057IRIS UNIMI author ID01714
P496ORCID iD0000-0001-6926-8660
P3368Prabook ID153961
P3829Publons author ID2105205
P1053ResearcherIDI-3965-2017
P1153Scopus author ID7004305333
P3987SHARE Catalogue author ID432270

P1416affiliationLuigi Sacco HospitalQ3886605
P27country of citizenshipItalyQ38
P69educated atUniversity of CataniaQ1248821
P108employerUniversity of MilanQ46210
P734family nameGismondoQ108810126
GismondoQ108810126
GismondoQ108810126
P101field of workvirologyQ7215
microbiologyQ7193
medical microbiologyQ598976
P735given nameMaria RitaQ55362076
Maria RitaQ55362076
P1412languages spoken, written or signedItalianQ652
EnglishQ1860
P1971number of children2
P106occupationuniversity teacherQ1622272
microbiologistQ3779582
virologistQ15634281
P21sex or genderfemaleQ6581072
P937work locationMilanQ490

Reverse relations

author (P50)
Q45822128A novel methodology for large-scale phylogeny partition
Q58388732Activity of a Lactobacillus acidophilus–Based Douche for the Treatment of Bacterial Vaginosis
Q45081602Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp.
Q47957009An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
Q44235805Bactericidal activity of levofloxacin, gatifloxacin, penicillin, meropenem and rokitamycin against Bacillus anthracis clinical isolates
Q39651721Can Drainage Using a Negative-Pressure Wound Therapy Device Replace Traditional Sample Collection Methods?
Q58388746Candida albicans cellular internalization: a new pathogenic factor?
Q58388714Case Study – Italy
Q41272049Comparative evaluation of the new xTAG GPP multiplex assay in the laboratory diagnosis of acute gastroenteritis. Clinical assessment and potential application from a multicentre Italian study.
Q58388841Comparative susceptibilities of organisms isolated in Sicily to cefotetan and other antibiotics
Q24804134Comparison of nested PCR and real time PCR of Herpesvirus infections of central nervous system in HIV patients
Q58388749Cytomegalovirus pp65 antigenemia in HIV patients: retrospective on 3 years study
Q40791700Diffusion and transmission of carbapenem-resistant Klebsiella pneumoniae in the medical and surgical wards of a university hospital in Milan, Italy
Q42781205Effect of linezolid in comparison with that of vancomycin on glycocalix production: in vitro study
Q40322672Epidemiological and clinical characteristics of pediatric gastroenteritis associated with new viral agents
Q54026610Epidemiology of Gram-negative antibiotic resistance in outpatients: a year of surveillance.
Q42352638Erratum to: Imported arboviral infections in Italy, July 2014-October 2015: a National Reference Laboratory report
Q40348977European Multicenter Study on Analytical Performance of DxN Veris System HCV Assay
Q39512497Favorable therapeutic response with an antiretroviral salvage regimen in an HIV-1-positive subject infected with a CRF11-cpx virus
Q44260558Genotyping in HIV drug resistance mutations: epidemiology in 145 patients
Q39425715Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy: Modeling from antiretroviral resistance cohort analysis (ARCA) national database
Q33927106Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients
Q38025491Imported Loa loa filariasis: three cases and a review of cases reported in non-endemic countries in the past 25 years
Q30148815Imported arboviral infections in Italy, July 2014-October 2015: a National Reference Laboratory report
Q54432368In vitro antimicrobial activity of a novel propolis formulation (Actichelated propolis).
Q33299938In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections
Q46557679In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin
Q50133416Inhibition of in vitro growth of enteropathogens by new Lactobacillus isolates of human intestinal origin
Q42845171Low rate of virological failure and maintenance of susceptibility to HIV‐1 protease inhibitors with first‐line lopinavir/ritonavir‐based antiretroviral treatment in clinical practice
Q54502983Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients.
Q39695271Real-time PCR assay for rapid detection of Bacillus anthracis spores in clinical samples
Q33736490Review of probiotics available to modify gastrointestinal flora.
Q38866063Salinomycin and other ionophores as a new class of antimalarial drugs with transmission-blocking activity
Q44950411Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides
Q46184277Serum and lung levels of thiamphenicol after administration of its glycinate N-acetylcysteinate ester in experimentally infected guinea pigs
Q36102566Transmission of resistant HIV type 1 variants and epidemiological chains in Italian newly diagnosed individuals
Q40534974Use of Dithiothreitol to Dislodge Bacteria From the Biofilm on an Aortic Valve in the Operating Theatre: A Case of Infective Endocarditis Caused by Staphylococcus aureus and Proteus mirabilis
Q36980842Vaccination with endosomal unknown epitopes produces therapeutic response in rheumatoid arthritis patients and modulates adjuvant arthritis of rats.

Search more.